Posts

Breakthrough in solid-state storage innovates how biolo...

Scientists have developed a novel method for storing biological materials such a...

Screening won’t solve racial disparities in melanoma ou...

Increased skin cancer screening in individuals with skin of color is not suffici...

UC San Diego health among first in nation to perform re...

In what could lead to a revolutionary advancement in the treatment of temporal l...

A demonstration of substituent effects in anti-aromatic...

Circularly conjugated compounds with 4n+2 pi-electrons are known as aromatic com...

Mirati’s KRAS Inhibitor Krazi Fails to Make It in Europe

Mirati Therapeutics has learned the hard way that a clearance from the U.S. Food...

American Society of Retinal Specialists raise concerns ...

The American Society of Retinal Specialists (ASRS) issued a letter to doctors ra...

FDA approves MeMed’s bacteria-versus-virus blood test t...

MeMed, an infectious disease diagnostic company, has achieved a significant mile...

ADC Therapeutics terminates Zynlonta study after FDA pu...

ADC Therapeutics has decided to terminate its Zynlonta trial after the FDA impos...

Private equity deals in pharmaceutical in Middle East a...

In the Middle East and Africa pharmaceutical industry, there were 4 private equi...

“The innovation just explodes”: The role of AI in accel...

Artificial intelligence (AI) has the potential to expedite the discovery of new ...

EMA supports Sandoz’s Tysabri biosimilar amid various e...

The EMA’s decision marks a further step in the biosimilar’s pathway to potential...

Roche snubs SQZ HPV 16 programme, leaving the beleaguer...

Partnerships, mergers, business combinations, and acquisitions could all be on t...

Astellas and PeptiDream enter protein degrader discover...

Astellas Pharma has entered a research partnership and licence agreement with Pe...

Alvotech and Teva step up biosimilars partnership

The two companies have expanded their agreement, making Teva more involved in ma...

EMA CHMP provides positive opinion for ViiV’s cabotegravir

The EMA CHMP has provided a positive opinion recommending grant of marketing aut...

Golgi and Breye partner to develop P2X7 receptor antago...

Golgi Neurosciences has joined forces with Breye Therapeutics for the developmen...